Jacobs Levy Equity Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.81M | Sell |
|
|||||
|
2025
Q2 | $4.39M | Sell |
|
|||||
|
2025
Q1 | $3.03M | Buy |
|
|||||
|
2024
Q4 | $2.33M | Sell |
|
|||||
|
2024
Q3 | $2.69M | Sell |
|
|||||
|
2024
Q2 | $2.14M | Buy |
|
|||||
|
2024
Q1 | $3M | Sell |
|
|||||
|
2023
Q4 | $2.3M | Buy |
|
|||||
|
2023
Q3 | $1.96M | Buy |
|
|||||
|
2023
Q2 | $1.23M | Buy |
|
|||||
|
2023
Q1 | $672K | Sell |
|
|||||
|
2022
Q4 | $1.16M | Sell |
|
|||||
|
2022
Q3 | $646K | Buy |
|
|||||
|
2022
Q2 | $275K | Sell |
|
|||||
|
2022
Q1 | $707K | Sell |
|
|||||
|
2021
Q4 | $6.19M | Buy |
|
|||||
|
2021
Q3 | $7.67M | Sell |
|
|||||
|
2021
Q2 | $11M | Buy |
|
|||||
|
2021
Q1 | $9.03M | Buy |
|
|||||
|
2020
Q4 | $5.59M | Buy |
|
|||||
|
2020
Q3 | $1.75M | Buy |
|
|||||
|
2020
Q2 | $6.34M | Sell |
|
|||||
|
2020
Q1 | $3.77M | Buy |
|
|||||
|
2019
Q4 | $2.29M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $738K | Sell |
|
|||||
|
2019
Q1 | $5.22M | Buy |
|
|||||
|
2018
Q4 | $2.29M | Buy |
|
|||||
|
2018
Q3 | $2.92M | Buy |
|
|||||
|
2018
Q2 | $2.76M | Buy |
|
|||||
|
2018
Q1 | $794K | Buy |
|
|||||
|
2017
Q4 | $541K | Buy |
|
|||||
|
2017
Q3 | $429K | Buy |
|
|||||
|
2017
Q2 | $280K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $123K | Buy |
|